Bronchogen

🔹 What is Bronchogen?

Class: Short peptide bioregulator derived from bronchial tissue, part of the Khavinson-style Russian organ-specific bioregulator line. Mechanism:

• Promotes cellular repair and regeneration within bronchial and pulmonary tissue, aimed at supporting overall lung function.
• Dampens chronic airway inflammation, a mechanism relevant to bronchitis, asthma, and other inflammatory lung conditions.
• Reinforces local immune defenses in the lungs, contributing to greater resilience against respiratory infection.

Primary focus:

• Respiratory health and lung capacity, recovery support following infection, trauma, or surgery affecting the lungs, and general management of chronic respiratory conditions.

---

🔹 Oral Capsule Dosage (primary route) Range: 20 mg per capsule, typically 1–2 capsules taken 1–2 times daily. Typical protocol: A course of 20–30 days is standard, with duration adjusted to baseline lung health and the specific goal of the protocol. Rationale: Oral dosing is the standard route for this class of short bioregulator peptide, aiming to deliver an organ-specific signal to bronchial and pulmonary tissue without the need for inhaled or injectable delivery.

---

🔹 Cycle Length Common cycle length: 20–30 days per course. Off-cycle: As with other bioregulators in this family, courses are typically run periodically rather than continuously, with breaks between cycles.

---

🔹 Optimal Dosing Window

• No specific time-of-day requirement is emphasized in the source material; consistency across the day (1–2x dosing) is the more relevant factor.
• Some users report timing courses around seasonal respiratory stress (e.g., cold/flu season) or recovery periods following a respiratory illness.

---

✅ Educational Integration Example (oral capsule)

• Example protocol: 20 mg capsule, once or twice daily, for a 20–30 day course, considered around recovery from respiratory infection or as periodic seasonal support.
• Frequently discussed alongside Chonluten, given the overlapping lung-tissue focus of the two peptides.

---

🔹 Stacking Strategy (Educational / Complementary) Since Bronchogen is focused on bronchial and pulmonary tissue support, complementary stacking tends to focus on the broader respiratory and immune systems: 🔸 Respiratory-Focused Bioregulators:

• Chonluten: Lung-tissue bioregulator with a closely related focus, sometimes used interchangeably or in sequence depending on whether bronchial or broader pulmonary tissue is the priority.

🔸 Immune Support:

• Thymogen, Crystagen: General immune-modulating bioregulators that may complement Bronchogen’s local respiratory immune effects.

Rationale: Bronchogen targets bronchial tissue specifically; stacking aims to reinforce lung resilience and systemic immune defense around it.

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.